Discontinued — last reported Q3 '23
ResMed Derivative assets decreased by 1.6% to $7.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.3%, from $9.90M to $7.39M. Over 3 years (FY 2022 to FY 2025), Derivative assets shows an upward trend with a 249.1% CAGR.
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Standard for large financial institutions with significant capital markets operations.
fin_derivative_assets| Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $160.00K | $14.62M | $5.45M | $2.41M | $4.33M | $21.37M | $1.81M | $2.43M | $24.66M | $12.56M | $9.90M | $6.81M | $8.07M | $7.52M | $7.39M |
| QoQ Change | — | >999% | -62.7% | -55.9% | +80.0% | +393.9% | -91.5% | +34.4% | +914.1% | -49.1% | -21.1% | -31.2% | +18.5% | -6.9% | -1.6% |
| YoY Change | — | — | — | >999% | — | +46.2% | -66.8% | +1.1% | +469.9% | -41.3% | +447.1% | +180.0% | -67.3% | -40.1% | -25.3% |